Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

PayPal Shares Under Scrutiny as Major Bank Issues Stark Downgrade

Robert Sasse by Robert Sasse
December 19, 2025
in Analysis, E-Commerce, Nasdaq, Tech & Software
0
PayPal Stock
0
SHARES
28
VIEWS
Share on FacebookShare on Twitter

PayPal Holdings, Inc. finds itself navigating turbulent market sentiment. The digital payments giant, whose stock has been in a prolonged downtrend, now faces intensified pressure following a severe reassessment from a prominent Wall Street institution. Morgan Stanley has slashed its rating on the equity to “Underweight” and dramatically reduced its price target from $74 to $51, suggesting significant potential downside from the current trading level around $60. The firm’s analysts point to deep-seated structural concerns, missed opportunities, and a competitive landscape where rivals like Stripe are seen gaining ground.

A Market Divided on Prospects

The investment community is starkly polarized regarding PayPal’s trajectory. On one side, Mizuho Securities maintains an “Outperform” recommendation with an $84 price objective, implying a potential 40% upside. This creates an extraordinary gap between the most bullish and bearish analyst projections on Wall Street. Mizuho’s stance is that the market is undervaluing PayPal’s capabilities in certain business segments.

This divergence in opinion follows a third-quarter earnings report that demonstrated some resilience. PayPal exceeded profit expectations, posting earnings per share of $1.34 against forecasts of $1.20, aided by disciplined cost management and performance in its credit segment. However, investor focus has decisively shifted from past quarterly beats to the long-term strategic challenges highlighted by skeptics.

Should investors sell immediately? Or is it worth buying PayPal?

Morgan Stanley’s Bearish Thesis

Morgan Stanley strategist James Faucette outlined three core vulnerabilities driving the downgrade. Firstly, he argues PayPal is poorly positioned to capitalize on the emerging trend of AI-driven “Agentic Commerce,” a domain where competitor Stripe is reportedly establishing a lead. Secondly, enhancements to PayPal’s flagship “Branded Checkout” product are viewed as progressing too slowly and failing to meaningfully boost engagement. Thirdly, the analyst believes the critical window to effectively monetize the large Venmo user base has largely closed, with intensified competition eroding earlier opportunities.

The new $51 price target sits substantially below the current share price and marks a stark contrast to the stock’s 52-week high of $93.25. Since the start of the year, PayPal’s market value has declined by approximately 40%, with the equity trading near its annual low.

The Path Forward

The immediate battleground for PayPal’s stock is the psychological $60 level. A sustained break below this support could trigger further selling pressure, while stabilization above it might provide the company time to demonstrate the efficacy of its strategic initiatives. The company operates in a deeply polarized environment, caught between doubts about its business model’s future relevance and hopes for a reassessment of its undervalued strengths. The coming weeks will likely determine which narrative gains the upper hand in the market.

Ad

PayPal Stock: Buy or Sell?! New PayPal Analysis from March 25 delivers the answer:

The latest PayPal figures speak for themselves: Urgent action needed for PayPal investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

PayPal: Buy or sell? Read more here...

Tags: PayPal
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock
Analysis

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Next Post
Alibaba Stock

Alibaba's AI Pivot: Balancing Commercialization Against Economic Headwinds

Nel ASA Stock

Nel ASA's Strategic Pivot Amid Operational Headwinds

Barrick Stock

Barrick Gold Secures Key Mali Mine and Charts Strategic North American Future

Recommended

E.ON Stock

E.ON’s Strong Performance Meets Regulatory Uncertainty

2 weeks ago
Global X MSCI Argentina ETF Stock

Argentina’s ETF: A Fragile Recovery Fueled by US Support?

6 months ago
Red Cat Stock

Military Contract Ignites Rally for Red Cat Shares

5 months ago
Bitcoin Stock

Bitcoin’s Rebound: A Sustainable Recovery or Bull Trap?

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

VanEck’s Junior Gold ETF Overhauls Holdings with Major Additions

Southern Silver Exploration Advances Key Mexican Project to Next Stage

Trending

Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

by Rodolfo Hanigan
March 25, 2026
0

In a surprising market reaction, shares of biotechnology firm Ocugen experienced a significant sell-off this week, even...

Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Intel Stock

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

March 25, 2026
35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

March 24, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen Shares Tumble Despite Positive Clinical Trial Results
  • Regulatory Proposal Sparks Sell-Off in Coinbase Shares
  • UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com